Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Cancers|July 13, 2024
A Head-to-Head Comparison of the First-Line Treatments for Locally Advanced or Metastatic Urothelial Cancer: Is There Still a Role for Chemotherapy?Lorenzo Gasperoni, Luna Del Bono, Andrea Ossato, et al.
Human Psychopharmacology|June 29, 2017
1-cyclohexyl-x-methoxybenzene derivatives, novel psychoactive substances seized on the internet market. Synthesis and in vivo pharmacological studies in miceAnna Fantinati, Andrea Ossato, Sara Bianco, et al.
Hospital Pharmacy|May 23, 2022
Dabigatran-Induced Nephropathy and Gastrointestinal Bleeding and Its Successful Treatment with Idarucizumab: A Case ReportFrancesca Marchesini, Andrea Ossato, Alberto Zendrini, et al.
Cancers|March 29, 2023
Application of the IPDfromKM-Shiny Method to Compare the Efficacy of Novel Treatments Aimed at the Same Disease Condition: A Report of 14 AnalysesAndrea Messori, Vera Damuzzo, Melania Rivano, et al.
Translational Lung Cancer Research|June 15, 2026
Long-term outcomes of ALK inhibitors in metastatic ALK-positive non-small cell lung cancer: an updated indirect comparison using reconstructed patient-level dataAndrea Ossato, Vera Damuzzo, Luna Del Bono, et al.
Cancers|November 27, 2025
Comparative Analysis of Maintenance Treatments in Patients with Newly Diagnosed Advanced Ovarian Cancer After First-Line Platinum-Based RegimensLorenzo Gasperoni, Luca Cancanelli, Andrea Ossato, et al.
Neurotoxicology|October 15, 2019
Novel halogenated synthetic cannabinoids impair sensorimotor functions in miceSabrine Bilel, Micaela Tirri, Raffaella Arfè, et al.
Hospital Pharmacy|November 19, 2024
Rapid Desensitization to Antitumoral Agents. Result from a Retrospective Study, DESARChRoberto Tessari, Andrea Ossato, Francesca Realdon, et al.
International Journal of Legal Medicine|July 30, 2018
Phenotypic effects of chronic and acute use of methiopropamine in a mouse modelFederica Foti, Matteo Marti, Andrea Ossato, et al.
Recenti Progressi in Medicina|November 1, 2022
[Application of artificial intelligence for an early comparison of efficacy between new cancer drugs.]Vera Damuzzo, Melania Rivano, Paolo Baldo, et al.
Pageof 4